Indegene IPO allotment today: How to check allotment status online on BSE, Link Intime

Indegene IPO allotment date: The Initial Public Offering (IPO) of healthcare tech firm Indegene concluded with an overall subscription of 69.91 times on Wednesday, May 9. Indegene shares are set to be listed on bourses on NSE, and BSE tentatively on Monday, May 13, after the finalisation of the allotment of shares today, May 9.

Indegene IPO subscription status

The Rs 1,841.75 crore IPO received bids for 2,01,81,78,162 shares against 2,88,66,677 shares on offer, as provisional exchange data.

The portion for Qualified Institutional Buyers (QIBs) got subscribed a whopping 197.55 times while the part for non-institutional investors received 55.07 times subscription. The quota for Retail Individual Investors (RIIs) garnered 7.95 times the subscription.

Indegene IPO allotment today: Here's a step-by-step guide on how to check the allotment status 

Those who participated in the Indegene IPO can check the status of their application online in two ways: through the BSE website and through the website of the registrar. 

Indegene IPO allotment status check on BSE

Step 1: Visit the official website of the BSE to check the status of the IPO application online. Login using the direct link: bseindia.com/investors/appli_check.aspx

Step 2: Select 'Equity' under 'Issue Type'

Step 3: Select 'Issue Name'. Either enter the application number in the box or provide your PAN details to proceed further

Step 4: Click 'submit'.

The status of your Indegene IPO application status will appear on the screen.

Indegene IPO allotment status check on status on Link Intime

Step 1: Log in at the direct Link Intime web link — linkintime.co.in/MIPO/Ipoallotment.html;

Step 2: Select-- Indegene IPO

Step 3: Bidder then has to enter PAN details

Step 4: Click on the 'Search' option.

The status of your Indegene IPO application status will appear on the screen.

Indegene IPO: Fund Utilisation

Funds raised through the fresh issue would be used to pay debt, fund capital expenditure requirements, payment of deferred consideration for one of its past acquisitions, fund inorganic growth and general corporate purposes.

What does Indegene do?

Founded in 1998, Indegene offers solutions that help enable biopharmaceutical, emerging biotech and medical devices companies to develop products, launch them in the market, and drive sales throughout their life cycle.

Kotak Mahindra Capital Company, Citigroup Global Markets India, J P Morgan India and Nomura Financial Advisory and Securities (India) are the managers to the offer.

(with PTI inputs)

For all other news related to business, politics, tech and auto, visit Zeebiz.com.